United Therapeutics Corp
XBER:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
XBER:UTH
|
US |
|
Amtech Systems Inc
NASDAQ:ASYS
|
US |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
Smith & Nephew PLC
F:NPWA
|
UK |
|
Bank of China Ltd
OTC:BACHY
|
CN |
|
B
|
Bank Mandiri (Persero) Tbk PT
XMUN:PQ9
|
ID |
|
N
|
Nederman Holding AB
F:5QR
|
SE |
|
A
|
Advantest Corp
XBER:VAN
|
JP |
|
S
|
Sumitomo Rubber Industries Ltd
SWB:108
|
JP |
|
T
|
Titanium Transportation Group Inc
F:I9V
|
CA |
|
Kitron ASA
OSE:KIT
|
NO |
|
Aritzia Inc
F:280
|
CA |
|
Thangamayil Jewellery Ltd
BSE:533158
|
IN |
|
Norsk Hydro ASA
F:NOHA
|
NO |
|
N
|
Novatek PAO
LSE:NVTK
|
RU |
|
H
|
Hongkong and Shanghai Hotels Ltd
XBER:HSG
|
HK |
|
B
|
boohoo group plc
F:1B9
|
UK |
|
M
|
Marks and Spencer Group PLC
DUS:MA6
|
UK |
|
B
|
Box Inc
F:3BX
|
US |
|
Fine Organic Industries Ltd
NSE:FINEORG
|
IN |
|
P
|
Pakuwon Jati Tbk PT
IDX:PWON
|
ID |
Bankruptcy Probability
United Therapeutics Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
United Therapeutics Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
24B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
239.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
United Therapeutics Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, United Therapeutics Corp has no debt.
You can find a full breakdown on its Balance Sheet.
